Literature DB >> 24670676

The inhibitory effect of shakuyakukanzoto on K+ current in H9c2 cells.

Azusa Suganami1, Kazuho Sakamoto, Tomoyuki Ono, Hirotake Watanabe, Nahoko Hijioka, Masahiro Murakawa, Junko Kimura.   

Abstract

Shakuyakukanzoto (shao-yao-gan-cao-tang) is a commonly used Chinese traditional herbal medicine for the treatment of acute pain with muscle cramp. However, its mechanism of action is unclear. We previously reported that a low concentration of Kanzo (licorice) and isoliquiritigenin, a component of licorice, inhibited the potassium (K(+)) current in H9c2 cells. Therefore, in the present study, we examined the effects of Shakuyakukanzoto, Shakuyaku or Kanzo on the K(+) current (IKur) in H9c2 cells. Shakuyakukanzoto inhibited IKur in a concentration-dependent manner. The half-maximal concentration of Shakuyakukanzoto was approximately 1.3 mg/mL and the Hill coefficient was 1.2. The order of potency of inhibiting IKur was Kanzo>Shakuyakukanzoto>Shakuyaku. Glycyrrhizin, a major component of licorice, had no inhibitory effect on IKur. A small interfering RNA experiment indicated that IKur was most likely to be Kv2.1 in H9c2 cells. Our results suggest that Shakuyakukanzoto may normalize intracellular and extracellular K(+) balance by inhibiting IKur and reducing K(+) efflux, while the Na(+)-K(+) pump promotes K(+) influx into myofibers. Consequently, excess K(+) may be reduced from external space of myofibers. This may be a part of the Shakuyakukanzoto mechanism for improving muscle pain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24670676     DOI: 10.5387/fms.2013-16

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  5 in total

1.  THE INHIBITORY EFFECT OF PACLITAXEL ON (Kv2.1) K+ CURRENT IN H9c2 CELLS.

Authors:  Naoko Kitamura; Kazuho Sakamoto; Tomoyuki Ono; Junko Kimura
Journal:  Fukushima J Med Sci       Date:  2015-05-19

2.  Effect of Shakuyakukanzoto on Chemotherapy-Induced Hiccups in Patients with Lung Cancer.

Authors:  Satoshi Kamoshida; Shinichiro Okauchi; Hajime Osawa; Gen Ohara; Katsunori Kagohashi; Hiroaki Satoh
Journal:  Eurasian J Med       Date:  2021-01-19

3.  Characteristics of Chinese herbal medicine usage in ischemic heart disease patients among type 2 diabetes and their protection against hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts.

Authors:  Fuu-Jen Tsai; Tsung-Jung Ho; Chi-Fung Cheng; Yi-Tzone Shiao; Wen-Kuei Chien; Jin-Hua Chen; Xiang Liu; Hsinyi Tsang; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Ju-Pi Li; Cheng-Wen Lin; Jaung-Geng Lin; Yu-Ching Lan; Yu-Huei Liu; Chien-Hui Hung; Jung-Chun Lin; Chih-Chien Lin; Chih-Ho Lai; Wen-Miin Liang; Ying-Ju Lin
Journal:  Oncotarget       Date:  2017-02-28

4.  Chinese Herbal Products for Non-Motor Symptoms of Parkinson's Disease in Taiwan: A Population-Based Study.

Authors:  Chien-Hung Lin; Hsienhsueh Elley Chiu; Szu-Ying Wu; Shih-Ting Tseng; Tzu-Chan Wu; Yu-Chiang Hung; Chung Y Hsu; Hsuan-Ju Chen; Sheng-Feng Hsu; Chun-En Kuo; Wen-Long Hu
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

5.  Jakyakgamcho-tang in the relief of delayed-onset muscle soreness in healthy adults: study protocol for a randomized, double-blind, placebo-controlled, crossover design clinical trial.

Authors:  Kyungsun Han; Ojin Kwon; So-Young Jung; In-Hwa Park; Man-Suk Hwang; Sun-Young Park; Eui-Hyoung Hwang; Jun-Hwan Lee
Journal:  Trials       Date:  2020-02-21       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.